Michael Geschwind is a Neurology physician. ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
400 Parnassus Ave 8th Fl Box 0137
San Francisco, CA 941430001
Telephone
415-476-6880Registry record last updated 9 Jul 2007.
Clinical trials
- Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) Study
Sponsor: University of Wisconsin, Madison
- Clinical Trial Readiness for SCA1 and SCA3
Sponsor: The Methodist Hospital Research Institute
- CJD (Creutzfeldt-Jakob Disease) Quinacrine Study
Sponsor: University of California, San Francisco
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Regeneron Pharmaceuticals, Inc.Program year20252 payments
- Lilly USA, LLCProgram year20245 payments$22,282openpaymentsdata.cms.gov ↗
- Teva Pharmaceuticals USA, Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
4 NIH research awards on record, funded 2003–2023 per NIH RePORTER. The latest:
- Tracking longitudinal change in presymptomatic genetic prion disease (TLC-Pre-gPrD)
University of California, San Francisco
FY2023$1,086,202R01AG062562 - Tracking longitudinal change in presymptomatic genetic prion disease (TLC-Pre-gPrD)
University of California, San Francisco
FY2022$1,146,463R01AG062562 - Tracking longitudinal change in presymptomatic genetic prion disease (TLC-Pre-gPrD)
University of California, San Francisco
FY2021$1,186,626R01AG062562
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Atte Meretoja
University of Helsinki
Bruce Miller, MD
University of California, San Francisco (UCSF)
Dennis Selkoe, MD
Brigham and Women's Hospital
Ettore Beghi
Mario Negri Institute for Pharmacological Research
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”